A detailed history of Lazard Asset Management LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Lazard Asset Management LLC holds 28,213 shares of JAZZ stock, worth $3.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,213
Previous 10 282030.0%
Holding current value
$3.51 Million
Previous $1,000 314300.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $2.84 Million - $3.28 Million
28,203 Added 282030.0%
28,213 $3.14 Million
Q1 2024

May 14, 2024

SELL
$115.19 - $132.77 $115 - $132
-1 Reduced 9.09%
10 $1,000
Q2 2023

Aug 14, 2023

BUY
$122.5 - $147.16 $1,347 - $1,618
11 New
11 $1,000
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $259 - $319
2 Added 0.52%
390 $62,000
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $47,344 - $60,281
374 Added 2671.43%
388 $51,000
Q2 2022

Aug 09, 2022

BUY
$141.59 - $168.66 $1,982 - $2,361
14 New
14 $2,000
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $48,497 - $69,665
-377 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$105.46 - $144.13 $28,263 - $38,626
-268 Reduced 41.55%
377 $53,000
Q2 2020

Aug 13, 2020

SELL
$95.68 - $121.88 $18,370 - $23,400
-192 Reduced 22.94%
645 $71,000
Q1 2020

May 14, 2020

BUY
$87.74 - $152.74 $29,041 - $50,556
331 Added 65.42%
837 $83,000
Q4 2019

Feb 13, 2020

BUY
$117.65 - $153.73 $35,765 - $46,733
304 Added 150.5%
506 $75,000
Q3 2019

Nov 14, 2019

BUY
$125.18 - $143.24 $25,286 - $28,934
202 New
202 $25,000
Q2 2019

Aug 14, 2019

SELL
$125.55 - $144.48 $88,889 - $102,291
-708 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$121.81 - $142.95 $84,414 - $99,064
693 Added 4620.0%
708 $101,000
Q4 2016

Jul 30, 2019

BUY
N/A
8 Added 114.29%
15 $1,000
Q2 2016

Jul 29, 2019

BUY
N/A
7
7 $0

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.8B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.